BMJ: ‘Adding a sulfonylurea to metformin looks safer than switching to one’

BMJ: ‘Adding a sulfonylurea to metformin looks safer than switching to one’

July 25 2018 Switching to sulfonylureas in type 2 diabetes has been linked with an increased risk...

Effect of omega-3 or other fatty acids on heart disease is negligible finds Cochrane review

Effect of omega-3 or other fatty acids on heart disease is negligible finds Cochrane review

July 19 2018 Cochrane researchers have published research indicating that omega 3 supplements...

DOACs associated with reduced risk of major bleeding compared to warfarin

DOACs associated with reduced risk of major bleeding compared to warfarin

July 11 2018 Direct oral anticoagulants (DOACs) have been associated with reduced risks of major...

Recorded penicillin allergy associated with increased risk of MRSA and C difficile

Recorded penicillin allergy associated with increased risk of MRSA and C difficile

July 3 2018 People who have a record of penicillin allergy are at an increased risk of developing...

MPS advises of need for better awareness of cauda equina red flag symptoms

MPS advises of need for better awareness of cauda equina red flag symptoms

May 9 2018 The Medical Protection Society is advising doctors of a revision to the NICE Clinical...

  • BMJ: ‘Adding a sulfonylurea to metformin looks safer than switching to one’

    BMJ: ‘Adding a sulfonylurea to metformin looks safer than switching to one’

    Wednesday, 25 July 2018 14:07
  • Effect of omega-3 or other fatty acids on heart disease is negligible finds Cochrane review

    Effect of omega-3 or other fatty acids on heart disease is negligible finds Cochrane review

    Thursday, 19 July 2018 10:36
  • DOACs associated with reduced risk of major bleeding compared to warfarin

    DOACs associated with reduced risk of major bleeding compared to warfarin

    Wednesday, 11 July 2018 13:22
  • Recorded penicillin allergy associated with increased risk of MRSA and C difficile

    Recorded penicillin allergy associated with increased risk of MRSA and C difficile

    Tuesday, 03 July 2018 16:51
  • MPS advises of need for better awareness of cauda equina red flag symptoms

    MPS advises of need for better awareness of cauda equina red flag symptoms

    Wednesday, 09 May 2018 16:01

a vaccination syringes image cbSeptember 6 2017

Provisional figures for vaccine effectiveness in the 2016-17 flu season have indicated a poor outcome for older people. 

 Data released by Public Health England showed an adjusted all age vaccine effectiveness (VE) of 39.8% against influenza-laboratory-confirmed primary care consultations for influenza. However, “effectiveness was 40.6% in 18-64 year olds, with no significant effectiveness in ≥65 year olds. VE was 57% for A(H3N2) for 2-17 year olds receiving quadrivalent live attenuated influenza vaccine and 78.6% for influenza B.”

Results for the flu vaccine nasal spray indicate that it reduced the risk of vaccinated children getting flu by 65.8% in across the UK

PHE said: “The flu strain and the flu vaccine, recommended by the World Health Organization, changes every year and the flu vaccine generally provides an important level of protection.

“This year we did not find that the vaccine was significantly effective in protecting against influenza for the over-65 population. This highlights the importance of the vaccine programme in children, which is intended to indirectly protect other vulnerable members of the community, as well as the children themselves.”

The lower effectiveness in the older population for the 2016-17 season “highlights the need to continue to expand the programme among the young, as by protecting them, we can also protect those at risk of severe disease.

“The childhood flu vaccine programme is being expanded to include children in school year 4 in 2017 to 2018. Also, 4 year olds, who were previously offered flu vaccination in general practice, will now be offered it at school in reception class. So all children from reception class through to year 4 will be offered flu vaccination in the forthcoming season.”

Link:
PHE announcement       
PHE ‘Research and analysis: Influenza vaccine effectiveness: 2016 to 2017 estimates’          

Clinical News

July 27 2018 Adolescent boys will be offered the human papilloma virus (HPV) vaccine to protect them from cancer, the Department of Health and Social Care has announced.
July 20 2018 Doctors are being reminded to ensure that any patient or other records which may be relevant to the UK Infected Blood Inquiry are not destroyed. Earlier this month, the Inquiry’s Chair, Sir...